All ready, the meeting, which I am watching via a webcast, is raising the veil on an internal battle within the FDA. Drug safety officials have now said for years that the signs that Avandia causes heart attacks are grave enough to warrant pulling the drug.
Merck is suffering through the hardest period of its history, after pulling arthritis drug Vioxx off pharmacy shelves because it doubled the risk of heart attack and stroke in a clinical study.